The Safety Profile of COVID-19 Vaccines: A Narrative Review
Abstract
The ongoing COVID-19 pandemic inflicted a considerable burden on health systems and individuals world-wide. Thus, scientists intended to propose beneficial treatments and vaccines to fight against this virus.However, vaccination remained the only effective way to reduce death and hospitalization due to COVID-19infection. To date, about five proposed COVID-19 vaccines have been approved as WHO emergency uselistings (EUL). Yet, their safety profile needs the following actions to be revealed: (1) more follow-up registrysystems and (2) global clinical trials in various countries in a period that they are experiencing a peak.By searching keywords 'COVID-19' and 'vaccination' in PubMed and Scopus databases, we aimed to sum-marize the current evidence in the literature regarding the safety profile (i.e., local and systemic adverseevents) of ten COVID-19 vaccines: (1) Pfizer/BioNTech, (2) Moderna, (3) Sputnik V, (4) Bharat, (5) CanSi-no, (6) Sinovac, (7) AstraZeneca, (8) Johnson & Johnson, (9) Novavax, and (10) Sinopharm. Moreover, wedemonstrated the data on the safety of heterologous schedules of these vaccines alongside further consider-ations in people with comorbidities and particular circumstances.Most of the COVID-19 vaccine adverse effects possess a mild-to-moderate, self-limiting nature. However,special circumstances such as severe hyper-sensitivity necessitate the use of an alternate COVID-19 vaccine.Vaccination is the only way to exit the global pandemic, and its benefits outweigh its adverse effects. Mean-while, people should be aware of the signs of the probable rare, severe reactions to the vaccine.